Biotech News
Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference
ir.carismatx.com2026-05-06 15:28 EST
PHILADELPHIA , Nov. 27, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM ) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Steven Kelly , President and Chief Executive